Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Co-IP showed that the G322V mutation dramatically decreased the interaction between TRIM37 and TRIM28 (Fig
Results clearly showed that the c-met-binding of LASSS-treated HGF ( blue bars 4 ) was more than double that of the control level of HGF ( gray bars 3 , with the wash-out step)
Endocr Rev 16:6386 Jrgensen JO (1991) Human growth hormone replacement therapy: pharmacological and clinical aspects
This reduction in oxidative burden allowed the immune system to function with vastly improved efficiency
US$ 29.74
US$ 22.48
US$ 27.42
US$ 25.22
